My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
November 2017
PATIENT CARE AND SCIENCE
ACIP Makes New Recommendations on Shingles, Mumps Vaccines

The Advisory Committee on Immunization Practices (ACIP) recently approved recommendations for shingles (herpes zoster) vaccines and mumps-containing vaccines, in addition to approving the 2018 immunization schedules.

ACIP advises the Centers for Disease Control and Prevention (CDC). Once CDC approves ACIP’s recommendations, they will be published in the Morbidity and Mortality Weekly Report (MMWR), at which time the recommendations will become official CDC policy.

Shingles Vaccine ACIP voted that herpes zoster subunit (HZ/su) vaccine is:

  • recommended for the prevention of herpes zoster and related complications for immunocompetent adults aged 50 years and older,
  • recommended for the prevention of herpes zoster and related complications for immunocompetent adults who previously received zoster vaccine live (ZVL),
  • preferred over ZVL for the prevention of herpes zoster and related complications.

Mumps-containing Vaccine

  • ACIP voted that persons previously vaccinated with two doses of a mumps-containing vaccine* who are identified by public health as at increased risk for mumps because of an outbreak should receive a third dose of a mumps-containing vaccine to improve protection against mumps disease and related complications.

  • *As stated in Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013: Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP); wording includes MMR and MMRV

Once published in the MMWR, CDC will add shingles and mumps vaccination information and educational materials to CDC’s website.

2018 Immunization Schedules

ACIP approved the 2018 Recommended Immunization Schedules for Children and Adolescents Aged 18 Years or Younger and the Recommended Schedules for Adults aged 19 Years or Older. The adult schedule will reflect the new herpes zoster vaccine recommendation. The new mumps vaccination recommendation will be reflected in footnotes. The schedules will also incorporate all actions taken by ACIP this year. The 2018 schedules will be released early next year with information about changes.

‘Netconference’ Will Address Hepatitis A and New ACIP Recommendations

CDC will host a “Current Issues in Immunization Netconference” on Wednesday, November 8, at 12:00 – 1:00 p.m. EST. This Netconference, designed to provide health care providers with the most up-to-date information on immunization, will discuss these new recommendations. The netconference will also provide information about hepatitis A guidance and consideration in light of recent hepatitis A outbreaks and current constraints related to the hepatitis A vaccine supply. Registration is available online. Registration is limited; however, an archived version will be posted to CDC’s website shortly after November 8.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
HIVMA Releases Guideline on HIV and Chronic Pain
ACIP Makes New Recommendations on Shingles, Mumps Vaccines
Weighing in on HHS Report on Vaccine Innovation
Updates on NIHís Next Generation Researchers Initiative
CLINICAL PRACTICE MANAGEMENT
IDSA to UHC: Donít Deny Payment for Cognitive Services
Reimbursement for Telemedicine Could Get Easier
How to Stay Abreast of CMSís Quality Payment Program
POLICY AND ADVOCACY
IDSA Remains Committed to Fighting Antimicrobial Resistance
FY2018 Funding News
IDSA Continues to Press for Diagnostics Reimbursement
FDA Public Workshop on Antimicrobial Susceptibility Tests
IDSA Member Testifies at New York State Hearing on Lyme Disease
GLOBAL HEALTH
Science Speaks Covers IDWeek, Union World Conference on Lung Health
Congressional Study Tour to CDC Global Health
EDUCATION AND RESOURCES
Fellowship in Stewardship and Resistance Receives CDC Funding
HIVMA Clinical Fellowship and Medical Students Program
PCORI Funding Announcement: Community-Acquired Pneumonia
FROM THE PRESIDENT
Maintaining Our Momentum
TOP STORIES
IDSA Launches Antimicrobial Stewardship Centers of Excellence Program
Updated Guideline on Infectious Diarrhea Now Available
IDWeek 2017 Recap
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.